Parkman Healthcare Partners’s Qiagen QGEN Stock Holding History

Parkman Healthcare Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500,000	Closed	-$20M	–	98
2026 Q1	$20M	Buy	500,000 +5,649	+1%	+$267K	2.06%	16
2025 Q4	$22.2M	Sell	494,351 -5,808	-1%	-$269K	2.12%	16
2025 Q3	$22.3M	Buy	500,159 +2,052	+0.4%	+$98.2K	2.33%	10
2025 Q2	$23.9M	Buy	498,107 +138,463	+39%	+$6.02M	2.75%	8
2025 Q1	$14.4M	Buy	359,644 +90,074	+33%	+$3.79M	1.71%	23
2024 Q4	$12.3M	Buy	269,570 +64,656	+32%	+$2.9M	1.64%	22
2024 Q3	$9.6M	Sell	204,914 -22,846	-10%	-$1.04M	1.23%	30
2024 Q2	$9.63M	Sell	227,760 -77,473	-25%	-$3.4M	1.29%	28
2024 Q1	$13.5M	Buy	305,233 +69,469	+29%	+$3.17M	1.66%	18
2023 Q4	$10.9M	Buy	+235,764	New	+$10M	1.53%	20

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parkman Healthcare Partners's QGEN Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 500,000 shares — an estimated $20M sold.

Parkman Healthcare Partners first reported a position in QGEN in Q4 2023 and held it in 10 quarters. The position peaked at $23.9M in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Parkman Healthcare Partners reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Parkman Healthcare Partners sold 500,000 Qiagen shares in Q2 2026, an estimated $20M.
Parkman Healthcare Partners first reported a position in Qiagen in Q4 2023 and held it in 10 quarters.
Parkman Healthcare Partners's Qiagen position peaked at $23.9M in Q2 2025.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.